EUCAST breakpoint tables version 16.1, valid from 2026-06-24. Key changes include expanded and revised breakpoints for anaerobic bacteria and a clarification on carbapenem use in carbapenemase-producing Enterobacterales.
How susceptibility testing accuracy, prescribing errors, and AMR diagnostics translate into measurable economic losses–and why even a 10% error rate can cost millions of rubles.